Diskussionsleitung: M. Gawaz (Tübingen), S. Massberg (München)
(P2223) | Multifaceted effects of genetically caused thrombocytopenia on the development of the Metabolic Syndrome in mice | |
N. Burkhard, J. Hoch, D. Stallmann, N. Schommer, K. Krauel, M. A. Hamad, P. H. Mangin, N. Gauchel, D. Dürschmied, N. Schanze (Freiburg, Mannheim; Strasbourg, FR) | ||
(P2224) | Connecting brain, metabolism, and cardiovascular disease: The role of the hypothalamic complement C3/C3a/C3aR axis in metabolic syndrome and cardiovascular sequels | |
E. Rawish, C. Gragoll, M. Schneider, Y. Sun, W. Raasch, H. Langer, I. Eitel (Lübeck, Mannheim) | ||
(P2225) | S1P-Rezeptor-1-Signaling reduziert die arterielle Thrombose durch Hochregulation von endothelialem Thrombomodulin | |
P. Mourikis, M. Benkhoff, B. Knoop, K. Trojovsky, S. Ahlbrecht, M. Barcik, S. Metry, C. Helten, L. K. Dannenberg, T. Hohlfeld, T. Zeus, M. Kelm, B. Levkau, A. Polzin (Düsseldorf) | ||
(P2226) | Cystic fibrosis transmembrane conductance regulator potentiators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients | |
E. Asmus, K. Weronika, M. C. Brack, C. Wittig, F. Behrens, L. Reinshagen, M. Pfeiffer, S. Schulz, B. Mandzimba-Maloko, L. Erfinanda, P.-L. Perret, L. Michalick, P. J. Smeele, E. H. T. Lim, C. E. van den Brom, A. B. A. Vonk, T. Kaiser, N. Suttorp, S. Hippenstiel, L. E. Sander, F. Kurth, U. Rauch-Kröhnert, U. Landmesser, A. Haghikia, R. Preißner, H. J. Bogaard, M. Witzenrath, W. M. Kuebler, R. Szulcek, S. Simmons (Berlin; Amsterdam, NL) | ||
(P2227) | Mechanosensing via a GpIIb-Src-Axis regulates platelet migration in vitro and in vivo | |
L. Nicolai (München) | ||
(P2228) | The Role of Tumor-Necrosis Receptor Associated Factor 1 (TRAF-1) and 5 (TRAF-5) in Platelet Activation | |
K. Wißkirchen, T. Marchini, D. Westermann, D. Wolf (Freiburg im Breisgau) | ||
(P2229) | Triggering ACKR3 and CXCR4 heterodimerization in platelets by targeting ACKR3 | |
V. Dicenta-Baunach, K. Kolb, A.-K. Rohlfing, M. Gawaz (Tübingen) | ||
(P2230) | Platelet-mediated control of revascularization by anaphylatoxin C5a receptor-dependent release of CXCL4 predicts adaption to vessel obstruction in patients | |
L. Baron, H. Nording, M. Meusel, T. Geisler, H. Langer (Lübeck, Tübingen, Mannheim) |